You are here: Industry Insights > lupin

News List

Lupin launches generic Acticlate Tablets in the US expressbpd
November 03, 2017
Lupin announced the launch of its Doxycycline Hyclate Tablets USP, 75 mg and 150 mg having received an approval from the United States Food and Drug Administration (USFDA) earlier.
Lupin net profit falls 31% in Q2 to Rs 455 biospectrumasia
November 01, 2017
The company reported net profit of Rs 662.9 in the same period of previous year. Total revenue from operations dropped 8 percent to Rs 3951.9 crore from Rs 4,290.5 crore
Lupin gets US FDA approval for testosterone topical solution expressbpd
October 26, 2017
Drug firm Lupin has received the final approval from the US health regulator for its testosterone topical solution.
Lupin to acquire Symbiomix Therapeutics expressbpd
October 12, 2017
Lupin announced that its US subsidiary, Lupin has acquired Symbiomix Therapeutics. Lupin had entered into an option to acquire the company earlier this year.
Lupin receives FDA approval for generic Corgard Tablets expressbpd
October 10, 2017
Nadolol Tablets are indicated for management of patients with angina pectoris and for the treatment of hypertension
Lupin receives FDA approval for generic Acticlate tablets expressbpd
September 30, 2017
They are indicated in the treatment of infections caused by various microorganisms and as an adjunctive therapy in severe acne
Lupin receives FDA approval for generic Clobex lotion expressbpd
September 27, 2017
It is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations
Lupin appoints Jim Loerop as Chief Corporate Development Officer expressbpd
September 19, 2017
He will be responsible for the company’s global M&A and business development functions
Lupin gets US FDA nod to market generic anti-bacterial drug expressbpd
September 14, 2017
Drug maker Lupin has received a US health regulator’s nod to market generic version of Flagyl tablets, a drug used to treat bacterial infections, in the American market.
Lupin gets USFDA nod to market anti-infections tablets expressbpd
September 12, 2017
The company’s product is a generic version of Pfizer’s Vibra tablets

Previous page 1 2 3 4 5 6 7 8 9 10 ... 19 20 Next page